|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 451/04 | |
| A61K 31/46 | |||
| A61P 29/00 | |||
| A61P 31/18 |
| (11) | Patento numeris | 1990341 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08163025.3 |
| Europos patento paraiškos padavimo data | 2001-05-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-11-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-01-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0014046 | 2000-05-26 | GB | |
| 0015835 | 2000-06-27 | GB |
| (72) |
Perros, Manoussos, GB
Price, David, Anthony, GB
Stammen, Blanda, Luzia, Christa, GB
Wood, Anthony, GB
|
| (73) |
Pfizer Limited,
Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US |
| (54) | Triazolyl tropane derivatives as CCR5 modulators |
| Triazolyl tropane derivatives as CCR5 modulators |